Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $224,276 - $1.16 Million
4,395 New
4,395 $979,000
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $452,343 - $530,734
-1,927 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $469,494 - $521,214
1,927 New
1,927 $513,000
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $315,230 - $356,816
-1,450 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $298,772 - $359,846
1,450 New
1,450 $362,000
Q4 2018

Feb 14, 2019

SELL
$204.73 - $257.93 $529,636 - $667,264
-2,587 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $251,249 - $275,968
1,078 Added 71.44%
2,587 $675,000
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $754,986 - $848,407
-3,628 Reduced 70.62%
1,509 $361,000
Q1 2018

May 15, 2018

SELL
$205.46 - $240.27 $265,865 - $310,909
-1,294 Reduced 20.12%
5,137 $1.11 Million
Q4 2017

Feb 14, 2018

BUY
$189.0 - $222.64 $535,059 - $630,293
2,831 Added 78.64%
6,431 $1.38 Million
Q3 2017

Nov 14, 2017

SELL
$186.89 - $198.9 $37,378 - $39,780
-200 Reduced 5.26%
3,600 $705,000
Q2 2017

Aug 29, 2017

BUY
N/A
3,800
3,800 $741,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.